_id
6915fe13bc934aba376b283b
Ticker
SQZB
Name
SQZ Biotechnologies Company
Exchange
PINK
Address
200 Arsenal Yards Boulevard, Watertown, MA, United States, 02472
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.sqzbiotech.com
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
Last Close
0.024
Volume
-
Current Price
0.024
Change
0
Last Updated
2026-01-07T12:18:41.726Z
Image
-
Ipo Date
-
Market Cap
707787
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-09-30
Revenue
0
Cost Of Revenue
2229000
Gross Profit
-2229000
Operating Expenses
23801000
Operating Income
-23801000
Interest Expense
-
Pretax Income
-23639000
Net Income
-23639000
Eps
-0.8015631821437805
Dividends Per Share
-
Shares Outstanding
29491125
Income Tax Expense
-
EBITDA
-13354000
Operating Margin
-
Total Other Income Expense Net
162000
Cash
10193000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
12087000
Property Plant Equipment
15396000
Total Assets
29788000
Payables
1913000
Short Term Debt
2397000
Long Term Debt
-
Total Liabilities
27907000
Equity
1881000
Bs_currency_symbol
USD
Depreciation
2764000
Change In Working Capital
-624000
Cash From Operations
-14532000
Capital Expenditures
0
Cash From Investing
15000
Cash From Financing
0
Net Change In Cash
-14517000
Cf_currency_symbol
USD
PE
-
PB
0.3762822966507177
ROE
-1256.7251461988303
ROA
-79.35745937961596
FCF
-14532000
Fcf Percent
-
Piotroski FScore
1
Health Score
24
Deep Value Investing Score
5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
5
Net Net Investing Score
2.5
Quality Investing Score
1
Value Investing Score
3.5
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
2229000
Quarters > 0 > income Statement > gross Profit
-2229000
Quarters > 0 > income Statement > operating Expenses
23801000
Quarters > 0 > income Statement > operating Income
-23801000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-23639000
Quarters > 0 > income Statement > net Income
-23639000
Quarters > 0 > income Statement > eps
-0.8015631821437805
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
29491125
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-13354000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
162000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
10193000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
12087000
Quarters > 0 > balance Sheet > property Plant Equipment
15396000
Quarters > 0 > balance Sheet > total Assets
29788000
Quarters > 0 > balance Sheet > payables
1913000
Quarters > 0 > balance Sheet > short Term Debt
2397000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
27907000
Quarters > 0 > balance Sheet > equity
1881000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-23639000
Quarters > 0 > cash Flow > depreciation
2764000
Quarters > 0 > cash Flow > change In Working Capital
-624000
Quarters > 0 > cash Flow > cash From Operations
-14532000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
15000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-14517000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.8015631821437805
Quarters > 0 > ratios > PB
0.3762822966507177
Quarters > 0 > ratios > ROE
-1256.7251461988303
Quarters > 0 > ratios > ROA
-79.35745937961596
Quarters > 0 > ratios > FCF
-14532000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
24
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
178000
Quarters > 1 > income Statement > cost Of Revenue
2248000
Quarters > 1 > income Statement > gross Profit
-2070000
Quarters > 1 > income Statement > operating Expenses
15038000
Quarters > 1 > income Statement > operating Income
-17108000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-16770000
Quarters > 1 > income Statement > net Income
-16770000
Quarters > 1 > income Statement > eps
-0.5686456518698422
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
29491125
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-14860000
Quarters > 1 > income Statement > operating Margin
-9611.23595505618
Quarters > 1 > income Statement > total Other Income Expense Net
338000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
24710000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
27685000
Quarters > 1 > balance Sheet > property Plant Equipment
24158000
Quarters > 1 > balance Sheet > total Assets
54148000
Quarters > 1 > balance Sheet > payables
1563000
Quarters > 1 > balance Sheet > short Term Debt
2659000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
29611000
Quarters > 1 > balance Sheet > equity
24537000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-16770000
Quarters > 1 > cash Flow > depreciation
2248000
Quarters > 1 > cash Flow > change In Working Capital
-1788000
Quarters > 1 > cash Flow > cash From Operations
-15270000
Quarters > 1 > cash Flow > capital Expenditures
47000
Quarters > 1 > cash Flow > cash From Investing
108000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-15162000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.5686456518698422
Quarters > 1 > ratios > PB
0.02884570240860741
Quarters > 1 > ratios > ROE
-68.34576354077515
Quarters > 1 > ratios > ROA
-30.970672970377482
Quarters > 1 > ratios > FCF
-15317000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-86.0505617977528
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
3052000
Quarters > 2 > income Statement > gross Profit
-3052000
Quarters > 2 > income Statement > operating Expenses
15203000
Quarters > 2 > income Statement > operating Income
-18255000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-17687000
Quarters > 2 > income Statement > net Income
-17687000
Quarters > 2 > income Statement > eps
-0.5997397522135897
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
29491125
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-15203000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
568000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
39872000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
44448000
Quarters > 2 > balance Sheet > property Plant Equipment
26404000
Quarters > 2 > balance Sheet > total Assets
73157000
Quarters > 2 > balance Sheet > payables
2485000
Quarters > 2 > balance Sheet > short Term Debt
4188000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
33001000
Quarters > 2 > balance Sheet > equity
40156000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-17687000
Quarters > 2 > cash Flow > depreciation
3052000
Quarters > 2 > cash Flow > change In Working Capital
-9832000
Quarters > 2 > cash Flow > cash From Operations
-23772000
Quarters > 2 > cash Flow > capital Expenditures
65000
Quarters > 2 > cash Flow > cash From Investing
-65000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-23837000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.5997397522135897
Quarters > 2 > ratios > PB
0.017625933857953982
Quarters > 2 > ratios > ROE
-44.045721685426834
Quarters > 2 > ratios > ROA
-24.176770507265196
Quarters > 2 > ratios > FCF
-23837000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
37
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
11943000
Quarters > 3 > income Statement > cost Of Revenue
3393000
Quarters > 3 > income Statement > gross Profit
8550000
Quarters > 3 > income Statement > operating Expenses
17720000
Quarters > 3 > income Statement > operating Income
-9170000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-13547000
Quarters > 3 > income Statement > net Income
-13547000
Quarters > 3 > income Statement > eps
-0.4593585358306948
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
29491125
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5777000
Quarters > 3 > income Statement > operating Margin
-76.78137821317927
Quarters > 3 > income Statement > total Other Income Expense Net
-4377000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
63709000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
384000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
68204000
Quarters > 3 > balance Sheet > property Plant Equipment
29391000
Quarters > 3 > balance Sheet > total Assets
107187000
Quarters > 3 > balance Sheet > payables
2511000
Quarters > 3 > balance Sheet > short Term Debt
6562000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
50039000
Quarters > 3 > balance Sheet > equity
57148000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-13547000
Quarters > 3 > cash Flow > depreciation
3393000
Quarters > 3 > cash Flow > change In Working Capital
-12369000
Quarters > 3 > cash Flow > cash From Operations
-20760000
Quarters > 3 > cash Flow > capital Expenditures
101000
Quarters > 3 > cash Flow > cash From Investing
-101000
Quarters > 3 > cash Flow > cash From Financing
331000
Quarters > 3 > cash Flow > net Change In Cash
-20530000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.4593585358306948
Quarters > 3 > ratios > PB
0.012385157835794778
Quarters > 3 > ratios > ROE
-23.705116539511444
Quarters > 3 > ratios > ROA
-12.638659538936626
Quarters > 3 > ratios > FCF
-20861000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.7467135560579419
Quarters > 3 > health Score
29
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
12196000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
72963000
Annuals > 0 > income Statement > operating Income
-60767000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-71643000
Annuals > 0 > income Statement > net Income
-71643000
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-498.2535257461463
Annuals > 0 > income Statement > total Other Income Expense Net
-12500000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-71643000
Annuals > 0 > cash Flow > depreciation
11452000
Annuals > 0 > cash Flow > change In Working Capital
-24613000
Annuals > 0 > cash Flow > cash From Operations
-74334000
Annuals > 0 > cash Flow > capital Expenditures
213000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
331000
Annuals > 0 > cash Flow > net Change In Cash
-74046000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-74547000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-6.1124139061987535
Annuals > 0 > health Score
38
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
21029000
Annuals > 1 > income Statement > cost Of Revenue
11684000
Annuals > 1 > income Statement > gross Profit
9794000
Annuals > 1 > income Statement > operating Expenses
85619000
Annuals > 1 > income Statement > operating Income
-80684000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-79464000
Annuals > 1 > income Statement > net Income
-79464000
Annuals > 1 > income Statement > eps
-2.7579309603780304
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
28812904
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-64141000
Annuals > 1 > income Statement > operating Margin
-383.6796804412954
Annuals > 1 > income Statement > total Other Income Expense Net
-3639000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
63709000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
384000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
68204000
Annuals > 1 > balance Sheet > property Plant Equipment
29391000
Annuals > 1 > balance Sheet > total Assets
107187000
Annuals > 1 > balance Sheet > payables
2511000
Annuals > 1 > balance Sheet > short Term Debt
13461000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
50039000
Annuals > 1 > balance Sheet > equity
57148000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-79464000
Annuals > 1 > cash Flow > depreciation
11684000
Annuals > 1 > cash Flow > change In Working Capital
-24205000
Annuals > 1 > cash Flow > cash From Operations
-83549000
Annuals > 1 > cash Flow > capital Expenditures
522000
Annuals > 1 > cash Flow > cash From Investing
-488000
Annuals > 1 > cash Flow > cash From Financing
4233000
Annuals > 1 > cash Flow > net Change In Cash
-79804000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-2.7579309603780304
Annuals > 1 > ratios > PB
0.012100330650241478
Annuals > 1 > ratios > ROE
-139.04948554630084
Annuals > 1 > ratios > ROA
-74.13585602731675
Annuals > 1 > ratios > FCF
-84071000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-3.99786009795996
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
27098000
Annuals > 2 > income Statement > cost Of Revenue
11030000
Annuals > 2 > income Statement > gross Profit
16068000
Annuals > 2 > income Statement > operating Expenses
84837000
Annuals > 2 > income Statement > operating Income
-68769000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-68741000
Annuals > 2 > income Statement > net Income
-68741000
Annuals > 2 > income Statement > eps
-2.492526517790231
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
27578844
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-57739000
Annuals > 2 > income Statement > operating Margin
-253.77887666986493
Annuals > 2 > income Statement > total Other Income Expense Net
28000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
143513000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
3095000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
150635000
Annuals > 2 > balance Sheet > property Plant Equipment
72889000
Annuals > 2 > balance Sheet > total Assets
226152000
Annuals > 2 > balance Sheet > payables
3971000
Annuals > 2 > balance Sheet > short Term Debt
9936000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
102176000
Annuals > 2 > balance Sheet > equity
123976000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-68741000
Annuals > 2 > cash Flow > depreciation
11030000
Annuals > 2 > cash Flow > change In Working Capital
-32938000
Annuals > 2 > cash Flow > cash From Operations
-82137000
Annuals > 2 > cash Flow > capital Expenditures
613000
Annuals > 2 > cash Flow > cash From Investing
-613000
Annuals > 2 > cash Flow > cash From Financing
55906000
Annuals > 2 > cash Flow > net Change In Cash
-26844000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.492526517790231
Annuals > 2 > ratios > PB
0.00533887410466542
Annuals > 2 > ratios > ROE
-55.44702200425888
Annuals > 2 > ratios > ROA
-30.39592840213662
Annuals > 2 > ratios > FCF
-82750000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-3.053730902649642
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
20998000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
20998000
Annuals > 3 > income Statement > operating Expenses
72056000
Annuals > 3 > income Statement > operating Income
-51058000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-50521000
Annuals > 3 > income Statement > net Income
-50521000
Annuals > 3 > income Statement > eps
-2.038261099144835
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
24786324
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-40115000
Annuals > 3 > income Statement > operating Margin
-243.15649109438993
Annuals > 3 > income Statement > total Other Income Expense Net
537000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
170357000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
2442000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
176831000
Annuals > 3 > balance Sheet > property Plant Equipment
52005000
Annuals > 3 > balance Sheet > total Assets
231141000
Annuals > 3 > balance Sheet > payables
3708000
Annuals > 3 > balance Sheet > short Term Debt
16420000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
103942000
Annuals > 3 > balance Sheet > equity
127199000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-50521000
Annuals > 3 > cash Flow > depreciation
10943000
Annuals > 3 > cash Flow > change In Working Capital
-7278000
Annuals > 3 > cash Flow > cash From Operations
-43151000
Annuals > 3 > cash Flow > capital Expenditures
1177000
Annuals > 3 > cash Flow > cash From Investing
57823000
Annuals > 3 > cash Flow > cash From Financing
116416000
Annuals > 3 > cash Flow > net Change In Cash
131102000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-2.038261099144835
Annuals > 3 > ratios > PB
0.004676701672182958
Annuals > 3 > ratios > ROE
-39.71807954465051
Annuals > 3 > ratios > ROA
-21.857221349738904
Annuals > 3 > ratios > FCF
-44328000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.1110581960186683
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.8015631821437805
Valuation > metrics > PB
0.3762822966507177
Valuation > final Score
70
Valuation > verdict
62.4% Undervalued
Profitability > metrics > ROE
-1256.7251461988303
Profitability > metrics > ROA
-195.5737569289319
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
14.836257309941521
Risk > metrics > Interest Coverage
-2.314146815751094
Risk > final Score
-3
Risk > verdict
High
Liquidity > metrics > Current Ratio
2.8044083526682133
Liquidity > metrics > Quick Ratio
2.8044083526682133
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-6
Prev Risks > 1
19
Prev Risks > 2
43
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:37:09.936Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-06
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-29
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.8
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.8
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-29
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-07
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-14
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
-0.46
Earnings History > 7 > eps Difference
0.46
Earnings History > 7 > surprise Percent
100
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-08
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.8
Earnings History > 8 > eps Estimate
-6.59
Earnings History > 8 > eps Difference
5.79
Earnings History > 8 > surprise Percent
87.8604
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.57
Earnings History > 9 > eps Estimate
-3.54
Earnings History > 9 > eps Difference
2.97
Earnings History > 9 > surprise Percent
83.8983
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.6
Earnings History > 10 > eps Estimate
-0.51
Earnings History > 10 > eps Difference
-0.09
Earnings History > 10 > surprise Percent
-17.6471
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-22
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.46
Earnings History > 11 > eps Estimate
-0.46
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-09
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.77
Earnings History > 12 > eps Estimate
-0.77
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.78
Earnings History > 13 > eps Estimate
-0.78
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-10
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.75
Earnings History > 14 > eps Estimate
-0.75
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-16
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.42
Earnings History > 15 > eps Estimate
-0.4
Earnings History > 15 > eps Difference
-0.02
Earnings History > 15 > surprise Percent
-5
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.8
Earnings History > 16 > eps Estimate
-0.5625
Earnings History > 16 > eps Difference
-0.2375
Earnings History > 16 > surprise Percent
-42.2222
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-04
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.68
Earnings History > 17 > eps Estimate
-0.5725
Earnings History > 17 > eps Difference
-0.1075
Earnings History > 17 > surprise Percent
-18.7773
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-11
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.59
Earnings History > 18 > eps Estimate
-0.56
Earnings History > 18 > eps Difference
-0.03
Earnings History > 18 > surprise Percent
-5.3571
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-18
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-1.03
Earnings History > 19 > eps Estimate
-0.715
Earnings History > 19 > eps Difference
-0.315
Earnings History > 19 > surprise Percent
-44.0559
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-10-09
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.59
Earnings History > 20 > eps Estimate
-1.16
Earnings History > 20 > eps Difference
0.57
Earnings History > 20 > surprise Percent
49.1379
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-02
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.86
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.86
Earnings History > 21 > surprise Percent
-
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAsset Sale and Plan of Liquidation and Dissolution Approved by SQZB Shareholders - Business Wire
2/29/2024
Asset Sale and Plan of Liquidation and Dissolution Approved by SQZB Shareholders Business Wire
Read more →7+ Companies That Had Their IPO in 2020: Best and Worst Performers 24/7 Wall St.
Read more →(Last Updated 2023-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of SQZ Biotechnologies Company
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.